| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGRAX | 10.75 | 0.12 | +1.13% |
| Goldman Sachs Strategic Growth A | |||
| GINGX | 23.22 | 0.25 | +1.09% |
| Goldman Sachs U.S. Equity ESG Ins | |||
| MFRJX | 59.06 | 0.50 | +0.85% |
| MFS Research R4 | |||
| STVTX | 10.49 | 0.08 | +0.77% |
| Virtus Ceredex Large-Cap Value Equity I | |||
| GSIKX | 18.07 | 0.06 | +0.33% |
| Goldman Sachs International Eq Inc Instl | |||
A.I.dvisor tells us that VALIF and LYBC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VALIF and LYBC's prices will move in lockstep.
| Ticker / NAME | Correlation To VALIF | 1D Price Change % | ||
|---|---|---|---|---|
| VALIF | 100% | N/A | ||
| LYBC - VALIF | 33% Poorly correlated | +1.20% | ||
| EDVR - VALIF | 26% Poorly correlated | +0.62% | ||
| SFDL - VALIF | 24% Poorly correlated | N/A | ||
| BAFN - VALIF | 24% Poorly correlated | +2.61% | ||
| OAKV - VALIF | 24% Poorly correlated | -0.14% | ||
More | ||||